The Lanier Law Firm

A Louisiana federal jury awarded Terrence Allen $9 billion in punitive damages against Takeda and Eli Lilly after finding they hid Actos's bladder cancer risk for years, with W. Mark Lanier serving as lead trial counsel in the first federal bellwether trial of the massive MDL.

A St. Louis jury in July 2018 awarded 22 women and their families $4.69 billion, the largest U.S. verdict of that year, finding that asbestos in Johnson & Johnson's talcum powder products caused ovarian cancer; a Missouri appellate court upheld $2.11 billion in 2020.

A Dallas federal jury awarded $1.04 billion to six California patients harmed by Johnson and Johnson's metal-on-metal Pinnacle hip implants, with W. Mark Lanier leading an eight-week trial that produced one of the largest product-liability verdicts of 2016.

After a six-week federal trial, a jury found three of the nation's largest retail pharmacy chains created a public nuisance by flooding Lake and Trumbull Counties, Ohio with opioid pills, and a judge ordered $650 million to fund a 15-year abatement plan.

In the second federal bellwether trial, a Dallas jury awarded five Texas plaintiffs $502 million against Johnson & Johnson and its DePuy unit over defective metal-on-metal Pinnacle hip implants, with W. Mark Lanier leading trial for the plaintiffs.

Hours before opening arguments in the first federal opioid bellwether trial, W. Mark Lanier and co-counsel secured a $260 million settlement from distributors AmerisourceBergen, Cardinal Health, and McKesson, plus manufacturer Teva, on behalf of Cuyahoga and Summit counties in Ohio.

A Texas jury handed down the first U.S. verdict against Merck over its withdrawn painkiller Vioxx, awarding $253 million to the widow of Robert Ernst after W. Mark Lanier persuaded jurors the drug caused Ernst's fatal heart attack.

A Dallas federal jury awarded six New York patients $247 million against Johnson and Johnson and its DePuy unit, finding that the metal-on-metal Pinnacle hip implant system was defectively designed and that the company concealed known risks from patients and surgeons.